Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 132489-69-1 Chemical Structure| 132489-69-1

Structure of (Z)-PUGNAc
CAS No.: 132489-69-1

Chemical Structure| 132489-69-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(Z)-PUGNAc is an effective O-GlcNAcase inhibitor, showing greater efficacy than the E-type O-GlcNAcase inhibitors.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (Z)-PUGNAc

CAS No. :132489-69-1
Formula : C15H19N3O7
M.W : 353.33
SMILES Code : CC(N[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O/1)C1=N\OC(NC2=CC=CC=C2)=O)=O
MDL No. :MFCD00145022

Safety of (Z)-PUGNAc

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H315-H319
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BHK cells 100 μM 18 h To investigate the effect of PUGNAc on Akt1 glycosylation and phosphorylation. Results showed that PUGNAc treatment led to accumulation of O-GlcNAc proteins and caused hypophosphorylation of Akt T308. Nat Cell Biol. 2010 Sep;12(9):876-85
Neonatal rat cardiac myocytes (NRCMs) 200 µM overnight Inhibition of O-GlcNAcase activity, increased O-GlcNAc levels, and reduced post-hypoxic cardiac myocyte death Circ Res. 2009 Jan 2;104(1):41-9
vascular smooth muscle cells (VSMCs) 100 μM 24 h To investigate the effect of PugNAc on vascular reactivity to phenylephrine. PugNAc increased vascular reactivity to phenylephrine, which was abolished by the Rho kinase inhibitor Y-27632 Cardiovasc Res. 2011 Feb 15;89(3):614-22
3T3-L1 adipocytes 100 μM 16 h Increased O-GlcNAc levels by inhibiting O-GlcNAcase, leading to insulin resistance Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5313-8
second-order mesenteric arteries 100µM 24 h increased vascular O-GlcNAc-protein content, enhanced PE-induced vascular contraction, and reduced ACh-induced vasodilation Hypertension. 2009 Feb;53(2):166-74
human retinal micro vascular endothelial cells (HRECs) 200 µM 12 h To investigate the association between O-GlcNAcylation and ROS generation, it was found that PUGNAc significantly attenuated the production of ROS (P<0.01) and increased the expression levels of antioxidant genes SOD and GPX. Int J Mol Med. 2015 Oct;36(4):1019-27

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice K18 Gly− transgenic mice Intraperitoneal injection 7 mg/kg Fas antibody injection after 48 hours To investigate the effect of combined PUGNAc and Fas treatment on K18 Gly? mice. Results showed that K18 Gly? mice were more susceptible to PUGNAc/Fas-induced injury, with increased liver hemorrhage, apoptosis, and decreased Akt1 T308 phosphorylation. Nat Cell Biol. 2010 Sep;12(9):876-85

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.83mL

0.57mL

0.28mL

14.15mL

2.83mL

1.42mL

28.30mL

5.66mL

2.83mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories